Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details)

v3.24.1
Stockholders' Equity - Summary of Activity and Information regarding Outstanding and Exercisable Options (Details) - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Equity [Abstract]    
Options Outstanding, Beginning balance 6,545,628  
Options outstanding, Granted 1,607,027  
Options Outstanding, Exercised (750)  
Options Outstanding, Cancelled/forfeited (401,753)  
Options Outstanding, Ending balance 7,750,152 6,545,628
Options Outstanding, Options exercisable 7,071,064  
Weighted Average Exercise Price, Beginning balance $ 2.55  
Weighted Average Exercise Price, Granted 2.55  
Weighted average Exercise Price, Exercised 1.91  
Weighted Average Exercise Price, Cancelled/forfeited 4.53  
Weighted Average Exercise Price, Ending balance 2.53 $ 2.55
Weighted Average Exercise Price, Options exercisable $ 2.38  
Weighted Average Remaining Contractual Term in Years 7 years 3 months 14 days 7 years 7 months 2 days
Weighted Average Remaining Contractual Term in Years, Options exercisable 7 years 1 month 13 days  
Aggregate Intrinsic Value $ 16,329  
Aggregate Intrinsic Value, Options exercisable $ 16,229